Compare Crocs, Inc. (CROX) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs McKesson Corporation — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while McKesson Corporation trades at $899.6 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 16.7× Crocs, Inc.'s market cap, and McKesson Corporation pays a 0.42% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.
| CROX | MCK | |
|---|---|---|
Market Cap | $6.31B | $105.14B |
Sector | Consumer Staples | Health |
52-Week High | $141.19 | $995.69 |
52-Week Low | $73.39 | $659.01 |
Enterprise Value | $7.83B | $111.67B |
Dividend Yield | — | 0.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
